M, G. Q., ME, P., JC, B., K, H., SL, Z., Y, Y., . . . M, D. K. (2025). Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): A global surveillance analysis.
Citación estilo ChicagoM, Garcia Quesada, et al. Serotype Distribution of Remaining Invasive Pneumococcal Disease After Extensive Use of Ten-valent and 13-valent Pneumococcal Conjugate Vaccines (the PSERENADE Project): A Global Surveillance Analysis. 2025.
Cita MLAM, Garcia Quesada, et al. Serotype Distribution of Remaining Invasive Pneumococcal Disease After Extensive Use of Ten-valent and 13-valent Pneumococcal Conjugate Vaccines (the PSERENADE Project): A Global Surveillance Analysis. 2025.